Topic archive

barrow neurological institute

12 stories

10/7/2026

FDA proposes strict ibogaine trial guidelines

Public input sought on inpatient care and heart monitoring

9/1/2026

The study aims to explore ibogaine's potential for treating PTSD and addiction.

8/21/2026

Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.

8/19/2026

Barrow Neurological Institute to test ibogaine's safety and efficacy in a state-funded trial.

8/19/2026

Barrow Neurological Institute to explore ibogaine's potential for PTSD and brain injuries.

8/10/2026

Grant supports research on ibogaine's potential in treating brain injuries.

8/10/2026

Arizona funds first U.S. ibogaine trial for traumatic brain injuries, starting 2027.

8/7/2026

Study explores ibogaine's potential for TBI, amid safety concerns and federal illegality.

8/6/2026

The trial will explore ibogaine's potential to treat traumatic brain injury, starting in 2027.

8/6/2026

The trial will explore ibogaine's potential in treating chronic TBI symptoms.

8/6/2026

Arizona-funded study explores ibogaine's potential for neurological disorders.

8/5/2026

Grant supports research into ibogaine's effects on neurological disorders.